Press release
Viral Inactivation Market Likely To Growth US$5.736 bn by 2025 At An CAGR Of 7.4%
Global Viral Inactivation Market: Overview
Viral clearance study is one of the most important aspect for clinical trials, for manufacturing and commercialization of biopharmaceutical products derived from human and animal sources. Biologics products developed from human, plants and animal resources represents the higher levels of risk for viral contamination as these sources are known to carry number of human as well as other pathogenic viruses. Viral contamination of these biologics products used for treatment of variety of disease can have the several implications right from severe clinical complications to economic loss.
Viral clearance studies in large scale bio manufacturing process ensures the viral safety of biological products by screening the raw materials, testing the process intermediates and evaluates the capability and effectiveness of manufacturing process to achieve the desired level of viral safety of biologic products. Several methods have been developed and are currently practiced by the biopharmaceutical companies and other end users to ensure the viral safety of biologics products. The methods includes chemical method, radiation method and other methods such as pasteurization and dry & moist heat treatment.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339670
Viral inactivation methods have broad applications in blood & blood components, vaccines production, cell & tissue culture products and other biologics products. These viral clearance method help maximize the production by establishing operational parameters at different stages without hampering product quality.
Global Viral Inactivation Market: Drivers
Rapid growth of biosimilars and biologics market in global biopharmaceutical industry, Regulatory compliances for viral inactivation of biologics products, and increasing number of new drugs approval are some of the key driving factors for the growth of global viral inactivation market during forecast period. In 2015, 51 drugs were approved out of which 45 drugs approved by Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) and 6 approved by Center for Biologics Evaluation and Research (CBER). Also In March 2015, the US FDA approved the first biosimilars product for marketing in the United States. Since then large number of biosimilars products have been filed for FDA clearance and many new applications are anticipated to be filed during forecast period.
It is estimated that more than US$ 100 Bn biologics products market will go off patent in next few years which will open the window for the biosimilars products market. This estimated growth in biosimilars market is projected to be key driving factor for global viral inactivation market. However the high cost of biologics and biosimilars products development and manufacturing and high cost of equipment for viral inactivation are likely to limit the growth of viral inactivation market during forecast period. Emergence of new viruses and development of vaccines against these viruses, development and adoption of newer viral inactivation methods and Growing application monoclonal antibodies and recombinant proteins for treatment of variety of diseases represents the new market opportunity for global viral inactivation market during forecast period.
View Sample PDF @ https://www.marketresearchreports.biz/reports/1339670/viral-inactivation-global-industry-market-research-reports.pdf
Global Viral Inactivation Market: Segmentation
Global viral inactivation market is broadly segmented in four segments on the basis of methods used for viral inactivation, by application, by end user and by region. Based on methods, viral inactivation market has been segmented into chemical methods, radiation method, and other methods of viral inactivation. Out of these methods, chemical method of viral inactivation dominated the market. Chemical method is further sub-segmented into solvent detergent method, use of alkylating agent method and pH concentration method. The Solvent detergent method is projected to account largest market share by the end of 2025.
Chemical method is considered as the robust & efficient method for inactivation of variety of enveloped viruses. Also this method of viral inactivation is found to be economic, safer and delivers higher levels of purity of sample/ media. These advantages of chemical method have made the end user the first preference for viral inactivation. Radiation method for viral inactivation is projected to witness highest CAGR during forecast period owing to increased adoption of this method by most of blood center in developed countries.
By application, global viral inactivation market is segmented into blood and blood products, vaccines and cell & tissue culture products. Blood and blood products dominated the market due to high cost of viral inactivation per unit of blood and blood components, increasing demand for plasma and platelets for transfusion therapy globally. The end user of global viral inactivation market includes the pharmaceutical and biotechnology companies, blood banks & hospitals, contract research organizations and other end users.
Geographically, the global viral inactivation market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, methods, applications and end-users. North America dominated the market and is anticipated to lose its market share to Asia Pacific region by the end of 2025.
Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339670
Global Viral Inactivation Market: Competitive Landscape
The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global viral inactivation market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the global viral inactivation market, and profiled in the report include Parker Hannifin Corporation, Merck & Co., Inc., Shandong Weigao Group Medical Polymer Company Limited, Sartorius AG, Cerus Corporation, Macopharma SA, Terumo BCT, Inc., Thermo Fisher Scientific Inc. and V.I.P.S. SA
Global Viral inactivation Market is segmented as given below:
Global Viral Inactivation Market, by Method
Chemical Method
Radiation Method
Other Methods
Global Viral Inactivation Market, by Application
Blood & Blood Products
Vaccines
Cell & Tissue Culture
Global Viral Inactivation Market, by End-user
Pharmaceutical & Biotechnology Companies
Blood Banks & Hospitals
Contract Research Organizations
Other
Global Viral Inactivation Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Table of Content
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Viral Inactivation market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Viral Inactivation Method Introduction
4.1.2. Industry Evolution / Developments
Chapter 5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Trends
5.5. Viral Inactivation market Analysis and Forecast, 2017 – 2025
5.5.1. Market Revenue Projections (US$ Mn), 2017-2025
5.6. Porter’s five forces analysis
5.7. Market Outlook
Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1339670&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viral Inactivation Market Likely To Growth US$5.736 bn by 2025 At An CAGR Of 7.4% here
News-ID: 869078 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Viral
Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/
Kits &…
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin.
According to study, “Anti-Viral Drug Therapy…
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,…
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period.
Gene therapy has included tools such as viral vectors…
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent…
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in…
